A Two-part, Randomized, Double-blind, Single-dose, Crossover Study to Compare Formulations Produced by Two Methods of Manufacture for Bioequivalence and Dissolution in Healthy Adult Volunteers
收藏DataCite Commons2025-02-10 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00009269/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This study is comprised of two discrete Parts. Part A is a 3-period cross over evaluating
relative bioavailability. Part B is a 2-period cross over evaluating bioequivalence. There
will be a minimum of a 7-day washout period between treatment periods. Participants will
participate in Part A or Part B, but not both. Approximately 200 participants will be
included in the study.
提供机构：
Vivli
创建时间：
2023-09-12
